Time for management to resign, page-37

The underlying issue here, is just the FACTS. Not one of us, likes to hold stock in a company getting a spanking - but for MSB what's the alternate, we need dollars and exposure to the markets those dollars will likely come from - to drive our late stage clinical candidates into the commercial market!

At the moment, we're a half pregnant maybe - that's DEATH to businesses like ours. The market is full of them "mid stage maybes", our Board has wisely understood that and said "No Way" - we're headed into and through PhIII's and into that rewarding marketplace.

You've got a choice:

1) be one of many "mid-stage maybes"
2) CSL MkII

To get to "2" you need dollars and MSB has gone after them > to keep going toward the marketplace! We HAVE to keep running the marathon to market or we DIE!

Remember too, there are other "smart people" in the world, right now working on their own nextgen curative treatments, for major medical markets, most from big capital market regions - they'll run right over us if we don't step it up!